Cargando…
Memantine has a nicotinic neuroprotective pathway in acute hippocampal slices after an NMDA insult
Memantine is a non-competitive antagonist with a moderate affinity to the N-methyl-D-Aspartate (NMDA) receptor. The present study assessed memantine’s neuroprotective activity using electrophysiology of ex-vivo hippocampal slices. Interestingly, a nicotinic component was necessary for memantine’s ne...
Autores principales: | Ferrer-Acosta, Yancy, Rodriguez-Massó, Sergio, Pérez, Dinely, Eterovic, Vesna A., Ferchmin, P.A., Martins, Antonio Henrique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026604/ https://www.ncbi.nlm.nih.gov/pubmed/35944748 http://dx.doi.org/10.1016/j.tiv.2022.105453 |
Ejemplares similares
-
Kinin-B2 Receptor Mediated Neuroprotection after NMDA Excitotoxicity Is Reversed in the Presence of Kinin-B1 Receptor Agonists
por: Martins, Antonio H., et al.
Publicado: (2012) -
In Vivo Evaluation of the Acute Systemic Toxicity of (1S,2E,4R,6R,7E,11E)-Cembratriene-4,6-diol (4R) in Sprague Dawley Rats
por: Sabeva, Nadezhda, et al.
Publicado: (2022) -
Galantamine potentiates the neuroprotective effect of memantine against NMDA-induced excitotoxicity
por: Lopes, João P, et al.
Publicado: (2013) -
Virtual Therapy with the NMDA Antagonist Memantine in Hippocampal Models of Moderate to Severe Alzheimer’s Disease, In Silico Trials
por: Świetlik, Dariusz, et al.
Publicado: (2022) -
Is Memantine Effective as an NMDA Receptor Antagonist in Adjunctive Therapy for Schizophrenia?
por: Kikuchi, Tetsuro
Publicado: (2020)